You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
宣泰醫藥(688247.SH):泊沙康唑腸溶片、鹽酸安非他酮緩釋片(II)首次被納入國家醫保目錄
格隆匯 01-18 21:56

格隆匯1月18日丨宣泰醫藥(688247.SH)公佈,根據《國家醫保局、人力資源社會保障部關於印發<國家基本醫療保險、工傷保險和生育保險藥品目錄(2022年)>的通知》,公司的2個產品——泊沙康唑腸溶片、鹽酸安非他酮緩釋片(II)通過了醫保談判,首次被納入國家醫保目錄。

泊沙康唑腸溶片、鹽酸安非他酮緩釋片(II)被納入國家醫保目錄,將有助於公司進一步提高上述藥物在患者中的可負擔性和可及性,有利於進一步推動上述藥物的市場推廣、提升銷售規模,對公司的長期經營發展具有積極影響。但產品的具體銷售情況可能會受到市場環境、渠道拓展等多重因素影響,對公司短期內經營業績的影響存在不確定性。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account